{"ORPHApacket":[{"ORPHApacketID":"3088","date":"2019-12-06 06:36:43","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"3088","Name":[{"lang":"en","label":"Revesz syndrome"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_3088","DisorderType":[{"Name":[{"lang":"en","label":"Malformation syndrome"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377789"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Rare constitutional aplastic anemia"}],"ORPHA":"68383","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_68383"},{"Name":[{"lang":"en","label":"Syndromic inherited retinal disorder"}],"ORPHA":"519325","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_519325"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"Revesz syndrome is a rare severe phenotypic variant of dyskeratosis congenita (DC; see this term) with an onset in early childhood, characterized by features of DC (e.g. skin hyper\/hypopigmentation, nail dystrophy, oral leukoplakia, high risk of bone marrow failure (BMF) and cancer, developmental delay sparse and fine hair) in conjunction with bilateral exudative retinopathy, and intracranial calcifications."}],"ExternalReferenceList":[{"count":"1","ExternalReference":[{"Source":"OMIM","Reference":"268130","DisorderMappingRelation":[{"id":"21527","Name":[{"lang":"en","label":"E (exact mapping (the terms and the concepts are equivalent))"}]}]}]}],"AverageAgeOfOnsetList":[{"count":"2","AverageAgeOfOnset":[{"Name":[{"lang":"en","label":"Childhood"}]},{"Name":[{"lang":"en","label":"Infancy"}]}]}],"TypeOfInheritanceList":[{"count":"1","TypeOfInheritance":[{"Name":[{"lang":"en","label":"Autosomal dominant"}]}]}],"SynonymList":[{"count":"3","Synonym":[{"lang":"en","label":"Dyskeratosis congenita with bilateral exudative retinopathy"},{"lang":"en","label":"Retinopathy-anemia-central nervous system anomalies syndrome"},{"lang":"en","label":"Revesz-DeBuse syndrome"}]}]}]}